UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease

Hepatology (Baltimore, Md.), 2019-02, Vol.69 (2), p.684-698

2019

Volltextzugriff (PDF)

OS-085 - Use of antidiabetic and lipid-lowering medications associated with lower scores of liver fibrosis biomarkers in non-alcoholic steatohepatitis (NASH) patients

Journal of hepatology, 2023-06, Vol.78, p.S69-S69

2023

Volltextzugriff (PDF)

Use of antidiabetic and lipid-lowering medications associated with lower scores of liver fibrosis biomarkers in non-alcoholic steatohepatitis (NASH) patients

Journal of hepatology, 2023-06, Vol.78, p.S69

2023

Volltextzugriff (PDF)

Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis

Hepatology (Baltimore, Md.), 2022-05, Vol.75 (5), p.1235-1246

2022

Volltextzugriff (PDF)

Effect of Renal Impairment on the Pharmacokinetics of Firsocostat, an Acetyl‐Coenzyme A Carboxylase Inhibitor, and Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist

Journal of clinical pharmacology, 2023-05, Vol.63 (5), p.560-568

2023

Volltextzugriff (PDF)

Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat

Clinical gastroenterology and hepatology, 2023-01, Vol.21 (1), p.143-152.e3

2023

Volltextzugriff (PDF)

THU033 - Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials

Journal of hepatology, 2020-08, Vol.73, p.S157-S158

2020

Volltextzugriff (PDF)

Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials

Journal of hepatology, 2020-08, Vol.73, p.S157-S158

2020

Volltextzugriff (PDF)

Derivation and validation of the nonalcoholic fatty liver disease cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosis

European journal of internal medicine, 2022-04, Vol.98, p.53-60

2022

Volltextzugriff (PDF)

Sa1570 Sex-Specific Differences in Patients With Primary Sclerosing Cholangitis

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S1070-S1070

2016

Volltextzugriff (PDF)

501 - Prospective Validation of the Enhanced Liver Fibrosis (ELF) Test for the Prediction of Disease Progression in a Randomized Trial of Patients with Primary Sclerosing Cholangitis (PSC)

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1060-S1060

2017

Volltextzugriff (PDF)

Prospective Validation of the Enhanced Liver Fibrosis (ELF) Test for the Prediction of Disease Progression in a Randomized Trial of Patients with Primary Sclerosing Cholangitis (PSC)

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1060-S1060

2017

Volltextzugriff (PDF)

Mechanical Properties and Microscopic Mechanism of Coral Sand-Cement Mortar

Advances in materials science and engineering, 2020, Vol.2020 (1)

2020

Volltextzugriff (PDF)

Experiment on Size Effect and Fractal Characteristics of Waste Brick and Concrete Recycled Aggregate

Advances in materials science and engineering, 2021, Vol.2021 (1)

2021

Volltextzugriff (PDF)

Online trace detection of mercury ions with enhanced fluorescence excitation within metal-lined hollow-core fiber

Optics letters, 2023-10, Vol.48 (19), p.5145-5148

2023

Volltextzugriff (PDF)

Review on All-Fiber Online Raman Sensor with Hollow Core Microstructured Optical Fiber

Photonics, 2022-03, Vol.9 (3), p.134

2022

Volltextzugriff (PDF)

An optically active isochroman-2H-chromene conjugate potently suppresses neuronal oxidative injuries associated with the PI3K/Akt and MAPK signaling pathways

Acta pharmacologica Sinica, 2021-01, Vol.42 (1), p.36-44

2021

Volltextzugriff (PDF)

Alpha-Adrenergic Agonists Stimulate Fluid Secretion in Lacrimal Gland Ducts

Investigative ophthalmology & visual science, 2020-12, Vol.61 (14), p.3-3

2020

Volltextzugriff (PDF)

The regulatory role of vasoactive intestinal peptide in lacrimal gland ductal fluid secretion: A new piece of the puzzle in tear production

Molecular vision, 2020, Vol.26, p.780-788

2020

Volltextzugriff (PDF)

Interactions of Desmethoxyyangonin, a Secondary Metabolite from Renealmia alpinia, with Human Monoamine Oxidase-A and Oxidase-B

Evidence-based complementary and alternative medicine, 2017-01, Vol.2017 (1), p.4018724-4018724

2017

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)
Tagungsberichte
(2)

Sprache

Englisch
(32)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(13)
Humans
(9)
Fibrosis
(5)
Gastroenterology & Hepatology
(5)
Liver - Pathology
(5)
Liver Cirrhosis
(5)
Animals
(4)
Cirrhosis
(4)
Hepatology
(4)
Biopsy
(3)
Collagen
(3)
Liver
(3)
Liver Cirrhosis - Drug Therapy
(3)
Liver Cirrhosis - Pathology
(3)
Liver Diseases
(3)
Male
(3)
Morphometry
(3)
Non-Alcoholic Fatty Liver Disease - Complications
(3)
Non-Alcoholic Fatty Liver Disease - Drug Therapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH

Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease

OS-085 - Use of antidiabetic and lipid-lowering medications associated with lower scores of liver fibrosis biomarkers in non-alcoholic steatohepatitis (NASH) patients

Use of antidiabetic and lipid-lowering medications associated with lower scores of liver fibrosis biomarkers in non-alcoholic steatohepatitis (NASH) patients

Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis

Effect of Renal Impairment on the Pharmacokinetics of Firsocostat, an Acetyl‐Coenzyme A Carboxylase Inhibitor, and Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist

Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis

Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat

The MRI and AST (MAST) score is correlated with noninvasive and histologic markers of fibrosis in patients with advanced fibrosis due to NASH

THU033 - Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials

Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials

Derivation and validation of the nonalcoholic fatty liver disease cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosis

LBO04 - Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial

Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial

Sa1570 Sex-Specific Differences in Patients With Primary Sclerosing Cholangitis

501 - Prospective Validation of the Enhanced Liver Fibrosis (ELF) Test for the Prediction of Disease Progression in a Randomized Trial of Patients with Primary Sclerosing Cholangitis (PSC)

Prospective Validation of the Enhanced Liver Fibrosis (ELF) Test for the Prediction of Disease Progression in a Randomized Trial of Patients with Primary Sclerosing Cholangitis (PSC)

Mechanical Properties and Microscopic Mechanism of Coral Sand-Cement Mortar

Experiment on Size Effect and Fractal Characteristics of Waste Brick and Concrete Recycled Aggregate

Online trace detection of mercury ions with enhanced fluorescence excitation within metal-lined hollow-core fiber

Review on All-Fiber Online Raman Sensor with Hollow Core Microstructured Optical Fiber

An optically active isochroman-2H-chromene conjugate potently suppresses neuronal oxidative injuries associated with the PI3K/Akt and MAPK signaling pathways

Alpha-Adrenergic Agonists Stimulate Fluid Secretion in Lacrimal Gland Ducts

The regulatory role of vasoactive intestinal peptide in lacrimal gland ductal fluid secretion: A new piece of the puzzle in tear production

Interactions of Desmethoxyyangonin, a Secondary Metabolite from Renealmia alpinia, with Human Monoamine Oxidase-A and Oxidase-B

Suchergebnisse filtern